Synaffix partners with SOTIO Biotech in deal worth up to $740m
SOTIO will gain access to Synaffix’s three ADC technologies
Read More
Tag: toxSYN
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
